Wasatch Advisors’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
BBHC
Wasatch Advisors's NVS Position: Q3 2018 in Review
Wasatch Advisors sold out of Novartis (NVS) in Q3 2018, closing a stake of 43,829 shares — an estimated $2.97M sold.
Wasatch Advisors first reported a position in NVS in Q2 2013 and held it in 21 quarters. The position peaked at $30.2M in Q3 2014. 1,028 funds tracked by Wall St. Rank hold NVS as of Q3 2018.
- Wasatch Advisors reported no remaining Novartis position as of Q3 2018 after selling out during the quarter.
- Wasatch Advisors sold 43,829 Novartis shares in Q3 2018, an estimated $2.97M.
- Wasatch Advisors first reported a position in Novartis in Q2 2013 and held it in 21 quarters.
- Wasatch Advisors's Novartis position peaked at $30.2M in Q3 2014.
- 1,028 funds tracked by Wall St. Rank held Novartis as of Q3 2018.
Based on Wasatch Advisors's 13F filing for Q3 2018, filed 7 Nov 2018.